• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump

    3/29/22 12:29:31 PM ET
    $AVAH
    $DOYU
    $IGMS
    $LOVE
    Medical/Nursing Services
    Health Care
    Computer Software: Programming Data Processing
    Technology
    Get the next $AVAH alert in real time by email

    U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday.

    The Dow traded up 0.75% to 35,217.99 while the NASDAQ rose 1.21% to 14,529.01. The S&P also rose, gaining, 0.77% to 4,610.6.

    Also check this: Alphabet And 3 Other Stocks Sold By Insiders


    Leading and Lagging Sectors


    Communication services shares jumped by 1.4% on Monday. Meanwhile, top gainers in the sector included VEON Ltd. (NASDAQ:VEON), up 16% and DouYu International Holdings Limited (NASDAQ:DOYU) up 10%.


    In trading on Monday, energy shares fell 1.8%.


    Top Headline


    McCormick & Co Inc (NYSE:MKC) reported better-than-expected earnings for its first quarter.


    McCormick reported first-quarter FY22 sales growth of 2.7% year-on-year, to $1.52 billion, beating the consensus of $1.47 billion. Adjusted EPS of $0.63 beat the consensus of $0.62.


    McCormick reiterated its FY22 sales, operating income, and EPS outlook. The company sees FY22 sales growth of 3% - 5% Y/Y. It expects FY22 Adjusted EPS of $3.17 - $3.22, against the consensus of $3.19.

     

    Equities Trading UP


    IGM Biosciences, Inc. (NASDAQ:IGMS) shares shot up 128% to $34.18. Sanofi SA (NASDAQ:SNY) and IGM Biosciences signed an exclusive worldwide collaboration agreement for IgM antibodies agonists against three oncology targets and three immunology/inflammation targets.


    Shares of Randolph Bancorp, Inc. (NASDAQ:RNDB) got a boost, shooting 26% to $26.49 after Hometown Financial Group announced plans to acquire Randolph Bancorp for $27 per share in cash.


    The Lovesac Company (NASDAQ:LOVE) shares were also up, gaining 22% to $57.42. Lovesac reported fourth-quarter FY22 sales growth of 51.3% year-on-year, to $196.2 million, beating the consensus of $174.33 million.


    Equities Trading DOWN

    NeoGenomics, Inc. (NASDAQ:NEO) shares tumbled 32% to $12.01 after the company announced it expects Q1 sales to be below its previously issued guidance range and withdrew its FY22 guidance. The company also announced Mark Mallon has agreed to step down as CEO.


    Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) were down 28% to $3.8650 after the company said FY21 EPS results were down from last year. The company also issued FY22 sales guidance below analyst estimates. B of A Securities downgraded the stock from Buy to Neutral and lowered the price target from $10 to $5.5.


    Progenity, Inc. (NASDAQ:PROG) was down, falling 24% to $1.2188 after the company reported Q4 earnings results.

    Also check out: Executives Buy More Than $12M Of 3 Stocks


    Commodities

    In commodity news, oil traded down 2.5% to $103.29, while gold traded down 1.6% to $1,908.90.


    Silver traded down 2.2% Tuesday to $24.635 while copper fell 0.1% to $4.7220.



    Euro zone

    European shares were higher today. The eurozone’s STOXX 600 gained 1.48%, London’s FTSE 100 rose 0.72%, while Spain’s IBEX 35 Index rose 2.94%. The German DAX gained 2.46%, French CAC 40 climbed 2.77% and Italy’s FTSE MIB Index rose 2.08%.

    Consumer credit in the UK rose by GBP 1.9 billion in February. Retail sales in Spain rose 0.9% year-over-year in February, while consumer confidence in France declined to 91 in March from 97 in February. Import prices in Germany rose 26.3% year-over-year in February, while GfK Consumer Climate Indicator declined to -15.5 heading to April.

     

    Economics

     

    The S&P CoreLogic Case-Shiller home price index increased 19.1% in January.


    The FHFA house price index rose 1.6% from a month ago in January.


    The Conference Board’s consumer confidence index rose to 107.20 in March, versus a revised level of 105.70.


    Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 9:30 p.m. ET.

    Check out this: Walmart And 3 Other Stocks Sold By Insiders

    Check out our premarket coverage here .


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 81,658,970 cases with around 1,004,240 deaths. India confirmed a total of at least 43,021,980 cases and 521,090 deaths, while Brazil reported over 29,852,340 COVID-19 cases with 659,010 deaths. In total, there were at least 483,970,220 cases of COVID-19 worldwide with more than 6,153,200 deaths.

    Get the next $AVAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVAH
    $DOYU
    $IGMS
    $LOVE

    CompanyDatePrice TargetRatingAnalyst
    Sanofi
    $SNY
    2/12/2026Buy → Neutral
    BofA Securities
    Sanofi
    $SNY
    1/27/2026Neutral
    Citigroup
    Sanofi
    $SNY
    1/16/2026Buy → Neutral
    UBS
    Sanofi
    $SNY
    1/6/2026Overweight → Equal Weight
    Barclays
    McCormick & Company Incorporated
    $MKC
    12/15/2025$75.00Hold → Buy
    Deutsche Bank
    Sanofi
    $SNY
    12/9/2025Buy → Neutral
    Guggenheim
    Aveanna Healthcare Holdings Inc.
    $AVAH
    12/8/2025Outperform
    William Blair
    Sanofi
    $SNY
    12/8/2025Overweight → Neutral
    Analyst
    More analyst ratings

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    V.P. & Controller Repas Gregory was granted 2,105 units of Common Stock - Voting, increasing direct ownership by 93% to 4,371 units (SEC Form 4)

    4 - MCCORMICK & CO INC (0000063754) (Issuer)

    3/6/26 1:07:58 PM ET
    $MKC
    Packaged Foods
    Consumer Staples

    SEC Form 4 filed by Chief Accounting Officer Aunan Greg D

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    3/3/26 6:16:42 PM ET
    $NEO
    Precision Instruments
    Health Care

    SEC Form 4 filed by EVP, GC & Business Development Olivo Alicia C

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    3/3/26 6:16:24 PM ET
    $NEO
    Precision Instruments
    Health Care

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    McCormick & Company to Report 2026 First Quarter Financial Results on March 31, 2026

    HUNT VALLEY, Md., March 10, 2026 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE:MKC), a global leader in flavor, is scheduled to conduct a conference call and webcast of its first quarter 2026 financial results on Tuesday March 31, 2026, at 8:00 a.m. Eastern Time. Brendan Foley, Chairman, President & CEO; Marcos Gabriel, Executive Vice President & CFO; and Faten Freiha, Vice President of Investor Relations will be hosting the call. A live audio webcast of the call along with the accompanying presentation materials will be available on the McCormick website ir.mccormick.com. If you are unable to attend the live webcast, the presentation will be archived on the same website. To listen

    3/10/26 4:15:00 PM ET
    $MKC
    Packaged Foods
    Consumer Staples

    VEON's Largest Market Pakistan Almost Triples Mobile Spectrum in Reform Push; Jazz Secures Largest Allocation with 190 MHz

    Islamabad, Dubai and New York - March 10, 2026: VEON Ltd. (NASDAQ:VEON, "VEON")), a global digital operator, is pleased to note the successful mobile spectrum auction held today in its largest market Pakistan. With the auction, the Pakistani Government nearly triples the spectrum available to mobile operators, with VEON's subsidiary Jazz, Pakistan's leading connectivity provider under JazzWorld, securing the largest allocation of 190 MHz. The auction increased the spectrum available to mobile operators from 274 MHz to 754 MHz, strengthening Pakistan's digital infrastructure and supporting faster broadband and next-generation digital services. Jazz's acquisition includes 50 MHz in the 3500 M

    3/10/26 9:30:00 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    VEON and JazzWorld Advance Pakistan's Digital Financial Future with Acquisition of TPL Insurance

    Acquisition to further financial inclusion through integrated digital financial services ecosystem Dubai, New York and Karachi – March 6, 2026 – VEON Ltd. (NASDAQ:VEON, "VEON")), a global digital operator, today announced that its subsidiary Jazz International Holding Limited ("JIH") has entered into a definitive agreement to acquire a controlling stake in TPL Insurance Limited ("TPL Insurance"), a publicly listed insurance firm in Pakistan. The transaction, which marks a new milestone for VEON's growing digital financial services portfolio in one of its most dynamic growth markets, is expected to close in mid-2026, subject to regulatory approvals. TPL Insurance, a digital-first insurance

    3/6/26 8:00:00 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sanofi downgraded by BofA Securities

    BofA Securities downgraded Sanofi from Buy to Neutral

    2/12/26 7:23:56 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Citigroup initiated coverage on Sanofi

    Citigroup initiated coverage of Sanofi with a rating of Neutral

    1/27/26 8:49:24 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sanofi downgraded by UBS

    UBS downgraded Sanofi from Buy to Neutral

    1/16/26 8:32:26 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    SEC Filings

    View All

    SEC Form 6-K filed by Sanofi

    6-K - Sanofi (0001121404) (Filer)

    3/10/26 10:40:54 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Sanofi

    6-K - Sanofi (0001121404) (Filer)

    3/4/26 12:26:19 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Sanofi

    6-K - Sanofi (0001121404) (Filer)

    3/3/26 6:15:15 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

    Submission status for SANOFI-AVENTIS US's drug SOLIQUA 100/33 (SUPPL-14) with active ingredient INSULIN GLARGINE; LIXISENATIDE has changed to 'Approval' on 11/01/2024. Application Category: BLA, Application Number: 208673, Application Classification:

    11/4/24 4:49:34 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Nelson Shawn David bought $14,410 worth of shares (1,000 units at $14.41), increasing direct ownership by 0.57% to 175,110 units (SEC Form 4)

    4 - Lovesac Co (0001701758) (Issuer)

    10/14/25 4:28:14 PM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    Chief Financial Officer Sherman Jeffrey Scott bought $112,322 worth of shares (20,000 units at $5.62), increasing direct ownership by 12% to 188,332 units (SEC Form 4)

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    8/6/25 4:07:57 PM ET
    $NEO
    Precision Instruments
    Health Care

    Chief Executive Officer Zook Anthony P. bought $99,954 worth of shares (17,900 units at $5.58), increasing direct ownership by 89% to 38,066 units (SEC Form 4)

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    8/6/25 4:07:25 PM ET
    $NEO
    Precision Instruments
    Health Care

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    Financials

    Live finance-specific insights

    View All

    McCormick & Company to Report 2026 First Quarter Financial Results on March 31, 2026

    HUNT VALLEY, Md., March 10, 2026 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE:MKC), a global leader in flavor, is scheduled to conduct a conference call and webcast of its first quarter 2026 financial results on Tuesday March 31, 2026, at 8:00 a.m. Eastern Time. Brendan Foley, Chairman, President & CEO; Marcos Gabriel, Executive Vice President & CFO; and Faten Freiha, Vice President of Investor Relations will be hosting the call. A live audio webcast of the call along with the accompanying presentation materials will be available on the McCormick website ir.mccormick.com. If you are unable to attend the live webcast, the presentation will be archived on the same website. To listen

    3/10/26 4:15:00 PM ET
    $MKC
    Packaged Foods
    Consumer Staples

    Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 19, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13757396. The replay will be available until March

    2/26/26 6:30:00 AM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    VEON to Release FY25 Earnings Update on March 13, 2026

    Dubai and New York, February 26, 2026 – VEON Ltd. (NASDAQ:VEON), a global digital operator (together with its subsidiaries "VEON Group" or "the Group"), today confirms that the Group will release its selected consolidated financial and operating results for the fourth quarter and full-year period ended December 31, 2025, at 8:00 GST (0:00 EST) on March 13, 2026. VEON Group will also host a results conference call with senior management at 16:00 GST (8:00 EST) on the same day. FY25 results conference call To register and access the event, please click here or copy and paste this link to the address bar of your browser: https://veon-fy25-and-4q25-results-presentation.open-exchange.net/ Onc

    2/26/26 4:30:00 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Lovesac Company

    SC 13G/A - Lovesac Co (0001701758) (Subject)

    11/14/24 4:34:24 PM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by NeoGenomics Inc.

    SC 13G/A - NEOGENOMICS INC (0001077183) (Subject)

    11/14/24 1:28:29 PM ET
    $NEO
    Precision Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by IGM Biosciences Inc.

    SC 13G/A - IGM Biosciences, Inc. (0001496323) (Subject)

    11/14/24 1:22:39 PM ET
    $IGMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVAH
    $DOYU
    $IGMS
    $LOVE
    Leadership Updates

    Live Leadership Updates

    View All

    MeetKai and GSMA Present ModelChorus at MWC26 Barcelona

    New global platform enables users to prompt and evaluate AI Models for under-resourced languages and regional dialectsBARCELONA, Spain, March 4, 2026 /PRNewswire/ -- MeetKai Inc. and the GSMA today announced their collaboration to launch ModelChorus, a new online platform designed to help mobile operators, model developers, and ecosystem partners evaluate language models and accelerate deployment of language ready AI across real world networks and devices. Visitors to MWC26 Barcelona can experience ModelChorus at the GSMA Pavilion in Hall 4 (Stand 4F30) at Fira Barcelona Gran Via or visit an alpha version of ModelChorus at www.modelchorus.com.

    3/4/26 9:00:00 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    Sanofi announces leadership evolution in Specialty Care Business Unit

    CAMBRIDGE, Mass., Feb. 17, 2026 /PRNewswire/ -- Sanofi today announced the appointment of Manuela Buxo as Head of Specialty Care, effective March 1, 2026. Manuela will succeed Brian Foard, who has decided to leave the company as of February 28, 2026, having accepted an external leadership opportunity. Brian joined Sanofi in 2017 and has held several senior leadership roles, most recently leading the Specialty Care Global Business Unit and serving as a member of the Executive Committee. During his tenure, Sanofi's Specialty Care strengthened its global position, driven by the launches of key medicines such as Dupixent across multiple indications and geographies. Manuela will lead Sanofi's Spe

    2/17/26 8:30:00 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    McCormick Appoints Gavin Hattersley and Rick Dierker to Board of Directors

    HUNT VALLEY, Md., Jan. 21, 2026 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE:MKC), a global leader in flavor, today announced that Gavin Hattersley, retired President and Chief Executive Officer of Molson Coors Beverage Company, and Rick Dierker, President and Chief Executive Officer of Church & Dwight Co., Inc., have been appointed to McCormick's Board of Directors effective February 1, 2026. Mr. Hattersley brings more than 35 years of leadership experience spanning the global consumer packaged goods and beverage industries. Most recently, he served as President an

    1/21/26 4:15:00 PM ET
    $MKC
    Packaged Foods
    Consumer Staples